CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Solon Eiendom ASA Company Snapshot
Solon Eiendom ASA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Solon Eiendom ASA with three other pharmaceutical manufacturers in Europe: Cathay International Holdings Ltd of the United Kingdom (2017 sales of £88.59 million [US$124.24 million] ), Bioton SA of Poland (361.65 million Polish New Zlotys [US$106.34 million] of which 59% was Insulin (Bioton SA)), and Zentiva SA which is based in Romania (458.60 million Romanian Leu [US$120.75 million] ).

Sales Analysis. During the year ended December of 2017, sales at Solon Eiendom ASA were NOK 883.04 million (US$112.60 million). This is an increase of 27.7% versus 2016, when the company's sales were NOK 691.50 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Solon Eiendom ASA
  Stock Performance Chart for Solon Eiendom ASA
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 28.00
(Figures in Norwegian Kroner)
1 Week 0.9%   13 Weeks 8.5%  
4 Weeks 32.0%   52 Weeks 25.8%  
 
Solon Eiendom ASA Key Data:
  Ticker: SOLON Country: Norway
  Exchanges: FRA LON OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 883,036,000
(Year Ending Jan 2018).
Employees: 19
  Currency: Norwegian Kroner Market Cap: 1,499,282,642
  Fiscal Yr Ends: December Shares Outstanding: 53,545,809
  Share Type: Ordinaere Aksje Closely Held Shares: 39,387,903
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.